{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:18:43Z","timestamp":1762157923353,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.parint.2022.102655","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T12:17:36Z","timestamp":1661343456000},"page":"102655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anti-malarial effect of a combination of risedronate and azithromycin against Plasmodium yoelii nigeriensis infection in Swiss mice"],"prefix":"10.1016","volume":"91","author":[{"given":"Solomon","family":"Tesfaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaleab","family":"Asres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prati Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2022.102655_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568008033340261","article-title":"Biosynthetic pathways of plastid-derived organelles as potential drug targets against parasitic apicomplexa","volume":"3","author":"Seeber","year":"2003","journal-title":"Current Drug Targets-Immune Endoc. Metab. Disord."},{"key":"10.1016\/j.parint.2022.102655_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/AAC.00808-06","article-title":"Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum","volume":"51","author":"Ramya","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","article-title":"Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum","volume":"7","author":"Surolia","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.parint.2022.102655_bb0020","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2174\/1381612043384006","article-title":"The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs","volume":"10","author":"Rodriguez-Concepcion","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.parint.2022.102655_bb0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00018-004-3381-z","article-title":"Biosynthesis of isoprenoids via the non-mevalonate pathway","volume":"61","author":"Eisenreich","year":"2004","journal-title":"Cell. Mol. Life Sci. CMLS."},{"key":"10.1016\/j.parint.2022.102655_bb0030","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.bmc.2019.07.004","article-title":"Synthesis and biological evaluation of 1-alkylaminomethyl-1, 1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii","volume":"27","author":"Galaka","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.parint.2022.102655_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01590-16","article-title":"In vitro and in vivo activities of sulfur-containing linear bisphosphonates against apicomplexan parasites","volume":"61","author":"Szajnman","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molbiopara.2019.03.001","article-title":"Farnesyl pyrophosphate synthase is essential for the promastigote and amastigote stages in Leishmania major","volume":"230","author":"Mukherjee","year":"2019","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.parint.2022.102655_bb0045","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/jm040132t","article-title":"Bisphosphonate Inhibitors of Toxoplasma g ondi Growth: in vitro, QSAR, and in vivo investigations","volume":"48","author":"Ling","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parint.2022.102655_bb0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1471-4922(01)02085-2","article-title":"Pyrimethamine\u2013sulfadoxine resistance in Plasmodium falciparum: what next?","volume":"17","author":"Sibley","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parint.2022.102655_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14728222.9.1.23","article-title":"The plastid-derived organelle ofprotozoan human parasites asa target of established and emerging drugs","volume":"9","author":"Wiesner","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.parint.2022.102655_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.parint.2022.102655_bb0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.exppara.2009.01.009","article-title":"Plasmodium berghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model","volume":"121","author":"Muregi","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2022.102655_bb0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0035-9203(87)90404-4","article-title":"The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice","volume":"81","author":"Chawira","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2022.102655_bb0080","first-page":"40","article-title":"Developing artemisinin-based drug combinations for the treatment of drug resistant falciparum malaria: a review","volume":"50","author":"Olliaro","year":"2004","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.parint.2022.102655_bb0085","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.parint.2022.102655_bb0090","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0035-9203(02)90063-5","article-title":"Drug sensitivity of Leishmania species: some unresolved problems","volume":"96","author":"Croft","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2022.102655_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijantimicag.2003.07.019","article-title":"Antiparasitic activity of risedronate in a murine model of acute Chagas\u2019 disease","volume":"23","author":"Garzoni","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.parint.2022.102655_bb0100","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/AAC.01820-10","article-title":"In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum","volume":"55","author":"Jord\u00e3o","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0105","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/AAC.00198-10","article-title":"Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth","volume":"54","author":"Singh","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0110","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2022.102655_bb0115","first-page":"801","article-title":"A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand., The Southeast Asian Journal of Tropical Medicine and Public","volume":"31","author":"Krudsood","year":"2000","journal-title":"Health."},{"key":"10.1016\/j.parint.2022.102655_bb0120","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","article-title":"Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro","volume":"46","author":"Ohrt","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0125","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/AAC.49.6.2372-2377.2005","article-title":"Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin","volume":"49","author":"Bosnar","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2022.102655_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcf.2007.05.005","article-title":"Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients","volume":"7","author":"Wilms","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.parint.2022.102655_bb0135","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1073\/pnas.1107899108","article-title":"Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates","volume":"108","author":"Norton","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576922001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576922001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:35:32Z","timestamp":1761302132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576922001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"alternative-id":["S1383576922001192"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2022.102655","relation":{},"ISSN":["1383-5769"],"issn-type":[{"type":"print","value":"1383-5769"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-malarial effect of a combination of risedronate and azithromycin against Plasmodium yoelii nigeriensis infection in Swiss mice","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2022.102655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102655"}}